| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABEONA THERAPEUTICS INC. | Director | Common Stock | 11K | $56.4K | $5.11 | Aug 13, 2024 | Direct |
| Entrada Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16K | Jun 13, 2024 | Direct | ||
| Amylyx Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 5.75K | Jun 6, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ABEO | ABEONA THERAPEUTICS INC. | Aug 13, 2024 | 1 | $0 | 4 | Aug 14, 2024 | Director |
| ABEO | ABEONA THERAPEUTICS INC. | Aug 8, 2024 | 0 | $0 | 3 | Aug 14, 2024 | Director |
| TRDA | Entrada Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| AMLX | Amylyx Pharmaceuticals, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mar 14, 2024 | 1 | $0 | 4 | Mar 15, 2024 | Director |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mar 14, 2024 | 0 | $0 | 3 | Mar 15, 2024 | Director |
| TRDA | Entrada Therapeutics, Inc. | Apr 4, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Director |
| TRDA | Entrada Therapeutics, Inc. | Apr 4, 2023 | 0 | $0 | 3 | Apr 4, 2023 | Director |